SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
The Federal Reserve Board has approved related applications submitted by Columbia Bank MHC and Columbia Financial, Inc. The approval allows these enti...
The FDA granted approval for Bizengri (zenocutuzumab-zbco), marking the seventh approval under the National Priority Voucher Pilot Program. The drug t...
The FDA released final guidance recommending methodologies for studying drug and biologic safety during pregnancy in the postapproval setting. The gui...
The FDA announced the launch of Elsa 4.0, an upgraded internal AI tool now available to all agency staff including scientific reviewers and investigat...
The FDA announced a pilot program for one-day inspectional assessments to make its inspectional resources more targeted and efficient. The initiative ...
The FDA approved the marketing of four Glas ENDS products through the premarket tobacco product application pathway. This authorization expands market...
The FDA issued a 'safe to proceed' letter to Revolution Medicines for an expanded access treatment protocol of daraxonrasib, an experimental pancreati...
Federal banking agencies have released loan-to-deposit ratios for host states, providing updated metrics on lending activity relative to deposits acro...
# FDA Approves Arvinas' VEPPANU (Vepdegestrant) for Oral Administration Arvinas Operations, Inc. received FDA approval for VEPPANU (vepdegestrant), a...
The FDA approved an expanded use for Auvelity (dextromethorphan/bupropion) to treat agitation associated with Alzheimer's dementia in adults. This mar...
The FDA is proposing to remove semaglutide, tirzepatide, and liraglutide from the 503B bulks list, determining there is no clinical need for outsourci...
The Federal Reserve's Federal Open Market Committee issued a statement regarding monetary policy decisions. The statement addresses current economic c...
The FDA released results from its largest and most rigorous examination of chemical contaminants in infant formula available in the U.S. market. The c...
The FDA announced two major steps to advance real-time clinical trials (RTCT) implementation. The initiative aims to modernize clinical trial processe...
The Federal Reserve Board has approved an application submitted by OceanFirst Financial Corp. The approval permits the company to proceed with its req...
The Federal Reserve Board has approved an application submitted by Banco de Credito del Peru. The approval allows the Peruvian financial institution t...
President Trump issued an Executive Order on April 18 directing HHS to accelerate access to treatments for serious mental illness, including treatment...
The Federal Reserve and banking agencies have finalized modifications to the community bank leverage ratio framework. The changes are designed to enha...
The FDA approved Otarmeni (lunsotogene parvec-cwha), marking the first dual AAV vector-based gene therapy for genetic hearing loss treatment. The appr...
CMS and FDA announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway to accelerate Medicare patient access to ...